Quantcast

Latest ovarian cancer Stories

2014-07-25 08:25:15

Phase I studies start in 2015 NEW HAVEN, Conn., July 25, 2014 /PRNewswire/ -- Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd. (ASX; NRT: NASDAQ; NVGN), today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil(TM). CanTx and Novogen expect to file an Investigational New Drug (IND) application for Cantrixil early next year and to advance this compound...

2014-07-24 23:13:07

Colleen’s Dream Foundation, in partnership with Fidelity National Title Agency, has donated $10,000 to Johns Hopkins Medicine to fund ovarian cancer research, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) July 24, 2014 Colleen’s Dream Foundation, in partnership with Fidelity National Title Agency, has donated $10,000 to Johns Hopkins Medicine to fund ovarian cancer research, according to Colleen’s Dream Foundation President Billy Cundiff....

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

Researchers Discover New Route For Ovarian Cancer Spread
2014-07-15 03:14:42

University of Texas M. D. Anderson Cancer Center HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer Cell. "This completely new way of thinking about ovarian cancer metastasis provides new potential...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

2014-07-01 16:26:50

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Ovarian Cancer Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diseases/cancer/global_ovarian_cancer_drugs_market.html About Ovarian Cancer and its therapyOvarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian...

2014-07-01 11:26:26

European Society of Human Reproduction and Embryology Oral contraceptive users have significantly lower measures of ovarian reserve than non-users A project in Denmark whose aim is to assess the reliability of preconceptional lifestyle and biological factors as predictors of fertility has found a pronounced effect of the contraceptive pill on markers used to assess "ovarian reserve", a predictor of future reproductive lifespan. Available evidence of whether the Pill has an effect on...

2014-06-30 12:31:36

In the practice of Gynecologic Oncology, Hereditary Cancer Risk, and Women's Health TEANECK, N.J., June 30, 2014 /PRNewswire/ -- Holy Name Medical Center (HNMC) welcomes gynecologic oncologist, hereditary cancer risk and women's health specialists Sharyn N. Lewin, MD, FACS, and Phyllis Tarallo, DNP, DCC, both of whom will be members of the Holy Name Physician Network. Dr. Lewin is a board-certified gynecologic oncologist specializing in the diagnosis, treatment and management of...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

2014-06-17 16:25:41

NEW YORK, June 17, 2014 /PRNewswire/ -- According to GLOBOCAN 2012, breast cancer was the second most commonly diagnosed form of cancer in 2012 with 1.7 million new cases, and accounting for nearly 12% of all new cancer cases. Since the 2008 estimates, breast cancer incidence has increased by more than 20% while mortality has increased by 14%. With approximately 522,000 deaths in 2012, breast cancer is now the most common cause of cancer death among women. Furthermore, it is...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'